A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
၅၉.၈၄ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၆, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
၅၉.၂၈ R$
High
၅၉.၈၄ R$
Low
၅၉.၂၈ R$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၄၄၆.၀၀
Volume
၁၇.၀၀
52-wk high
၁၃၁.၈၀ R$
52-wk low
၅၀.၂၅ R$
Shares outstanding
၁၃.၃၈ ကုဋေ
No. of employees
၂ ထောင်
Open
၅၉.၂၈ R$
High
၅၉.၈၄ R$
Low
၅၉.၂၈ R$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၄၄၆.၀၀
Volume
၁၇.၀၀
52-wk high
၁၃၁.၈၀ R$
52-wk low
၅၀.၂၅ R$
Shares outstanding
၁၃.၃၈ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
BofA cuts target to USD 336.00 for Alnylam Pharmaceuticals stock
Alnylam
·
ပြီးခဲ့သည့် ၃ ရက်
Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr